Rankings
▼
Calendar
AMRN Q4 2018 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$335M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$77M
+43.6% YoY
Gross Profit
$60M
77.4% margin
Operating Income
-$32M
-41.1% margin
Net Income
-$34M
-43.5% margin
EPS (Diluted)
$-2.14
QoQ Revenue Growth
+39.8%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$32M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$386M
Total Liabilities
$233M
Stockholders' Equity
$152M
Cash & Equivalents
$249M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$77M
$54M
+43.6%
Gross Profit
$60M
$40M
+47.9%
Operating Income
-$32M
-$7M
-344.2%
Net Income
-$34M
-$22M
-49.9%
Revenue Segments
Product
$77M
100%
License
$245,000
0%
← FY 2018
All Quarters
Q1 2019 →